Retinopathy of prematurity (ROP) is an ocular vascular disease affecting premature infants,
characterized by pathological retinal neovascularization (RNV), dilated and tortuous retinal …

Retinopathy of prematurity treatment modalities have expanded over the years, from
cryotherapy to laser therapy and now, anti-vascular endothelial factor (VEGF) therapy by …

Blood vessels in the developing retina are formed in concert with neural growth, resulting in
functional neurovascular network. Disruption of the neurovascular coordination contributes …

Hemizygous pathogenic variants in CACNA1F lead to defective signal transmission from
retinal photoreceptors to bipolar cells and cause incomplete congenital stationary night …

The retinopathy of prematurity (ROP), a neovascular retinal disorder presenting in premature
infants, is the leading causes of blindness in children. Currently, there is no approved drug …

Psychomotor delay, hypotonia, and intellectual disability, as well as heart defects, urogenital
malformations, and characteristic cranio-facial dysmorphism are the main symptoms of …

To circumvent possible systemic side effects, anti-angiogenic drugs that target vascular
endothelial growth factor (VEGF) for the treatment of proliferative ocular diseases are …

Objective To evaluate foveal thickness, foveal microvasculature, and refractive error in
children with asymmetric involvement of retinopathy of prematurity who had laser treatment …

Objective Retinopathy of prematurity (ROP) is a leading cause of childhood visual
impairment. Treatment options for severe ROP include laser and/or anti–vascular …

Hemizygous pathogenic variants in CACNA1F lead to defective signal transmission from
retinal photoreceptors to bipolar cells and cause incomplete congenital stationary night …